1
|
Chen D, Shen J, Zhao W, Wang T, Han L,
Hamilton JL and Im HJ: Osteoarthritis: Toward a comprehensive
understanding of pathological mechanism. Bone Res. 5:160442017.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Buckwalter JA, Saltzman C and Brown T: The
impact of osteoarthritis: Implications for research. Clin Orthop
Relat Res. (Suppl 427): S6–S15. 2004. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bitton R: The economic burden of
osteoarthritis. Am J Manag Care. 15(Suppl 8): S230–S235.
2009.PubMed/NCBI
|
4
|
Goldring MB and Otero M: Inflammation in
osteoarthritis. Curr Opin Rheumatol. 23:471–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Liu-Bryan R and Terkeltaub R: Emerging
regulators of the inflammatory process in osteoarthritis. Nat Rev
Rheumatol. 11:35–44. 2015. View Article : Google Scholar :
|
6
|
Daheshia M and Yao JQ: The interleukin 1β
pathway in the pathogenesis of osteoarthritis. J Rheumatol.
35:2306–2312. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Park C, Jeong JW, Lee DS, Yim MJ, Lee JM,
Han MH, Kim S, Kim HS, Kim GY, Park EK, et al: Sargassum
serratifolium extract attenuates interleukin-1β-induced oxidative
stress and inflammatory response in chondrocytes by suppressing the
activation of NF-κB, p38 MAPK, and PI3K/Akt. Int J Mol Sci.
19:E23082018. View Article : Google Scholar
|
8
|
Ding QH, Cheng Y, Chen WP, Zhong HM and
Wang XH: Celastrol, an inhibitor of heat shock protein 90beta
potently suppresses the expression of matrix metalloproteinases,
inducible nitric oxide synthase and cyclooxygenase-2 in primary
human osteoarthritic chondrocytes. Eur J Pharmacol. 708:1–7. 2013.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Roman-Blas JA and Jimenez SA: NF-kappaB as
a potential therapeutic target in osteoarthritis and rheumatoid
arthritis. Osteoarthritis Cartilage. 14:839–848. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Chen WP, Hu ZN, Jin LB and Wu LD:
Licochalcone A inhibits MMPs and ADAMTSs via the NF-κB and
Wnt/β-catenin signaling pathways in rat chondrocytes. Cell Physiol
Biochem. 43:937–944. 2017. View Article : Google Scholar
|
11
|
Largo R, Alvarez-Soria MA, Díez-Ortego I,
Calvo E, Sánchez-Pernaute O, Egido J and Herrero-Beaumont G:
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human
osteoarthritic chondrocytes. Osteoarthritis Cartilage. 11:290–298.
2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Frisbie DD, Ghivizzani SC, Robbins PD,
Evans CH and McIlwraith CW: Treatment of experimental equine
osteoarthritis by in vivo delivery of the equine interleukin-1
receptor antagonist gene. Gene Ther. 9:12–20. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Clements KM, Price JS, Chambers MG, Visco
DM, Poole AR and Mason RM: Gene deletion of either
interleukin-1beta, interleukin-1beta-converting enzyme, inducible
nitric oxide synthase, or stromelysin 1 accelerates the development
of knee osteoarthritis in mice after surgical transection of the
medial collateral ligament and partial medial meniscectomy.
Arthritis Rheum. 48:3452–3463. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chevalier X, Giraudeau B, Conrozier T,
Marliere J, Kiefer P and Goupille P: Safety study of intraarticular
injection of interleukin 1 receptor antagonist in patients with
painful knee osteoarthritis: A multicenter study. J Rheumatol.
32:1317–1323. 2005.PubMed/NCBI
|
15
|
Yi PF, Wu YC, Dong HB, Guo Y, Wei Q, Zhang
C, Song Z, Qin QQ, Lv S, Wu SC and Fu BD: Peimine impairs
pro-inflammatory cytokine secretion through the inhibition of the
activation of NF-κB and MAPK in LPS-induced RAW264.7 macrophages.
Immunopharmacol Immunotoxicol. 35:567–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xu J, Zhao W, Pan L, Zhang A, Chen Q, Xu
K, Lu H and Chen Y: Peimine, a main active ingredient of
Fritillaria, exhibits anti-inflammatory and pain suppression
properties at the cellular level. Fitoterapia. 111:1–6. 2016.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Cho IH, Lee MJ, Kim JH, Han NY, Shin KW,
Sohn Y and Jung HS: Fritillaria ussuriensis extract inhibits the
production of inflammatory cytokine and MAPKs in mast cells. Biosci
Biotechnol Biochem. 75:1440–1445. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Park JH, Lee B, Kim HK, Kim EY, Kim JH,
Min JH, Kim S, Sohn Y and Jung HS: Peimine inhibits the production
of proinflammatory cytokines through regulation of the
phosphorylation of NF-kappaB and MAPKs in HMC-1 cells. Pharmacogn
Mag. 13(Suppl 2): S359–S364. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wu K, Mo C, Xiao H, Jiang Y, Ye B and Wang
S: Imperialine and verticinone from bulbs of Fritillaria wabuensis
inhibit pro-inflammatory mediators in LPS-stimulated RAW 264.7
macrophages. Planta Med. 81:821–829. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Gosset M, Berenbaum F, Thirion S and
Jacques C: Primary culture and phenotyping of murine chondrocytes.
Nat Protoc. 3:1253–1260. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chen K, Lv ZT, Cheng P, Zhu WT, Liang S,
Yang Q, Parkman VA, Zhou CH, Jing XZ, Liu H, et al: Boldine
ameliorates estrogen deficiency-induced bone loss via inhibiting
bone resorption. Front Pharmacol. 9:10462018. View Article : Google Scholar : PubMed/NCBI
|
22
|
Schindelin J, Rueden CT, Hiner MC and
Eliceiri KW: The ImageJ ecosystem: An open platform for biomedical
image analysis. Mol Reprod Dev. 82:518–529. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
24
|
Shohet RV, Kisanuki YY, Zhao XS, Siddiquee
Z, Franco F and Yanagisawa M: Mice with cardiomyocyte-specific
disruption of the endothelin-1 gene are resistant to hyperthyroid
cardiac hypertrophy. Proc Natl Acad Sci USA. 101:2088–2093. 2004.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Mu X, Urso ML, Murray K, Fu F and Li Y:
Relaxin regulates MMP expression and promotes satellite cell
mobilization during muscle healing in both young and aged mice. Am
J Pathol. 177:2399–2410. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Li S, Zhang Y, Sun Y, Cao W and Cui L:
Exposure to fermentation supernatant of Staphylococcus aureus
accelerated dedifferentiation of chondrocytes and production of
antimicrobial peptides. J Orthop Res. 36:443–451. 2018.
|
27
|
Kim JH, Lee G, Won Y, Lee M, Kwak JS, Chun
CH and Chun JS: Matrix cross-linking-mediated mechanotransduction
promotes posttraumatic osteoarthritis. Proc Natl Acad Sci USA.
112:9424–9429. 2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Pritzker KP, Gay S, Jimenez SA, Ostergaard
K, Pelletier JP, Revell PA, Salter D and van den Berg WB:
Osteoarthritis cartilage histopathology: Grading and staging.
Osteoarthritis Cartilage. 14:13–29. 2006. View Article : Google Scholar
|
29
|
Chowdhury TT, Bader DL and Lee DA: Dynamic
compression inhibits the synthesis of nitric oxide and PGE(2) by
IL-1beta-stimulated chondrocytes cultured in agarose constructs.
Biochem Biophys Res Commun. 285:1168–1174. 2001. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yang G, Im HJ and Wang JH: Repetitive
mechanical stretching modulates IL-1beta induced COX-2, MMP-1
expression, and PGE2 production in human patellar tendon
fibroblasts. Gene. 363:166–172. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Kaminska B: MAPK signalling pathways as
molecular targets for anti-inflammatory therapy-from molecular
mechanisms to therapeutic benefits. Biochim Biophys Acta.
1754:253–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Loeser RF, Erickson EA and Long DL:
Mitogen-activated protein kinases as therapeutic targets in
osteoarthritis. Curr Opin Rheumatol. 20:581–586. 2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Brittberg M, Gomoll AH, Canseco JA, Far J,
Lind M and Hui J: Cartilage repair in the degenerative ageing knee.
Acta Orthop. 87:26–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Helmick CG, Felson DT, Lawrence RC,
Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD,
Merkel PA, et al: Estimates of the prevalence of arthritis and
other rheumatic conditions in the United States. Part I Arthritis
Rheum. 58:15–25. 2008. View Article : Google Scholar
|
35
|
Lawrence RC, Felson DT, Helmick CG, Arnold
LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG,
et al: Estimates of the prevalence of arthritis and other rheumatic
conditions in the United States. Part II Arthritis Rheum. 58:26–35.
2008. View Article : Google Scholar
|
36
|
Huang X, Pan Q, Mao Z, Zhang R, Ma X, Xi Y
and You H: Sinapic acid inhibits the IL-1β-induced inflammation via
MAPK down-regulation in rat chondrocytes. Inflammation. 41:562–568.
2018. View Article : Google Scholar
|
37
|
Pan T, Shi X, Chen H, Chen R, Wu D, Lin Z,
Zhang J and Pan J: Geniposide suppresses interleukin-1β-induced
inflammation and apoptosis in rat chondrocytes via the
PI3K/Akt/NF-κB signaling pathway. Inflammation. 41:390–399. 2018.
View Article : Google Scholar
|
38
|
Pelletier JP, McCollum R, Cloutier JM and
Martel-Pelletier J: Synthesis of metalloproteases and interleukin 6
(IL-6) in human osteoarthritic synovial membrane is an IL-1
mediated process. J Rheumatol Suppl. 43:109–114. 1995.PubMed/NCBI
|
39
|
Amin AR, Dave M, Attur M and Abramson SB:
COX-2, NO, and cartilage damage and repair. Curr Rheumatol Rep.
2:447–453. 2000. View Article : Google Scholar : PubMed/NCBI
|
40
|
Abramson SB, Attur M, Amin AR and Clancy
R: Nitric oxide and inflammatory mediators in the perpetuation of
osteoarthritis. Curr Rheumatol Rep. 3:535–541. 2001. View Article : Google Scholar : PubMed/NCBI
|
41
|
Fan Z, Bau B, Yang H, Soeder S and Aigner
T: Freshly isolated osteoarthritic chondrocytes are catabolically
more active than normal chondrocytes, but less responsive to
catabolic stimulation with interleukin-1beta. Arthritis Rheum.
52:136–143. 2005. View Article : Google Scholar : PubMed/NCBI
|
42
|
Elliott S, Hays E, Mayor M, Sporn M and
Vincenti M: The triterpenoid CDDO inhibits expression of matrix
metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in
primary human chon-drocytes. Arthritis Res Ther. 5:R285–R291. 2003.
View Article : Google Scholar
|
43
|
Arasapam G, Scherer M, Cool JC, Foster BK
and Xian CJ: Roles of COX-2 and iNOS in the bony repair of the
injured growth plate cartilage. J Cell Biochem. 99:450–461. 2006.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Nah SS, Choi IY, Lee CK, Oh JS, Kim YG,
Moon HB and Yoo B: Effects of advanced glycation end products on
the expression of COX-2, PGE2 and NO in human osteoarthritic
chondrocytes. Rheumatology (Oxford). 47:425–431. 2008. View Article : Google Scholar
|
45
|
Loeser RF: Molecular mechanisms of
cartilage destruction: Mechanics, inflammatory mediators, and aging
collide. Arthritis Rheum. 54:1357–1360. 2006. View Article : Google Scholar : PubMed/NCBI
|
46
|
Ishiguro N, Kojima T and Poole AR:
Mechanism of cartilage destruction in osteoarthritis. Nagoya J Med
Sci. 65:73–84. 2002.
|
47
|
van den Berg WB: Osteoarthritis year 2010
in review: Pathomechanisms. Osteoarthritis Cartilage. 19:338–341.
2011. View Article : Google Scholar : PubMed/NCBI
|
48
|
Huang K and Wu LD: Aggrecanase and
aggrecan degradation in osteoarthritis: A review. J Int Med Res.
36:1149–1160. 2008. View Article : Google Scholar : PubMed/NCBI
|
49
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|